 |
The Journal of Neuroscience, March 26, 2008, 28(13):3277-3290; doi:10.1523/JNEUROSCI.0116-08.2008
Previous Article | Next Article 
Neurobiology of Disease
Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes
Szu-Yi Chou,1,2
Ju-Yun Weng,3
Hsing-Lin Lai,2
Fang Liao,2
Synthia H. Sun,3
Pang-Hsien Tu,2
Dennis W. Dickson,4 and
Yijuang Chern1,2,3
1Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 104, Taiwan, 2Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei 115, Taiwan, 3Institute of Neuroscience, National Yang-Ming University, Taipei 112, Taiwan, and 4Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida 32224
Correspondence should be addressed to Yijuang Chern, Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei 115, Taiwan. Email: bmychern{at}ibms.sinica.edu.tw
Huntington's disease (HD) is a hereditary neurological disease caused by expended CAG repeats in the HD gene, which codes for a protein called Huntingtin (Htt). The resultant mutant Huntingtin (mHtt) forms aggregates in neurons and causes neuronal dysfunction. In astrocytes, the largest population of brain cells, mHtt also exists. We report herein that astrocyte-conditioned medium (ACM) collected from astrocytes of R6/2 mice (a mouse model of HD) caused primary cortical neurons to grow less-mature neurites, migrate more slowly, and exhibit lower calcium influx after depolarization than those maintained in wild-type (WT) ACM. Using a cytokine antibody array and ELISA assays, we demonstrated that the amount of a chemokine [chemokine (C-C motif) ligand 5 (CCL5)/regulated on activation normal T cell expressed and secreted (RANTES)] released by R6/2 astrocytes was much less than that by WT astrocytes. When cortical neurons were treated with the indicated ACM, supplementation with recombinant CCL5/RANTES ameliorated the neuronal deficiency caused by HD-ACM, whereas removing CCL5/RANTES from WT-ACM using an anti-CCL5/RANTES antibody mimicked the effects evoked by HD-ACM. Quantitative PCR and promoter analyses demonstrated that mHtt hindered the activation of the CCL5/RANTES promoter by reducing the availability of nuclear factor B-p65 and, hence, reduced the transcript level of CCL5/RANTES. Moreover, ELISA assays and immunocytochemical staining revealed that mHtt retained the residual CCL5/RANTES inside R6/2 astrocytes. In line with the above findings, elevated cytosolic CCL5/RANTES levels were also observed in the brains of two mouse models of HD [R6/2 and Hdh(CAG)150] and human HD patients. These findings suggest that mHtt hinders one major trophic function of astrocytes which might contribute to the neuronal dysfunction of HD.
Key words: astrocyte; trophic; release; Huntington; neuron; transcription
Received Aug. 24, 2007;
accepted Feb. 7, 2008.
Correspondence should be addressed to Yijuang Chern, Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei 115, Taiwan. Email: bmychern{at}ibms.sinica.edu.tw
This article has been cited by other articles:

|
 |

|
 |
 
J. Palazuelos, T. Aguado, M. R. Pazos, B. Julien, C. Carrasco, E. Resel, O. Sagredo, C. Benito, J. Romero, I. Azcoitia, et al.
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
Brain,
November 1, 2009;
132(11):
3152 - 3164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, F. Lin, J. Wu, and Z. Qin
High efficiency adenovirus-mediated expression of truncated N-terminal huntingtin fragment (htt552) in primary rat astrocytes
Acta Biochim Biophys Sin,
April 1, 2009;
41(4):
325 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tydlacka, C.-E. Wang, X. Wang, S. Li, and X.-J. Li
Differential Activities of the Ubiquitin-Proteasome System in Neurons versus Glia May Account for the Preferential Accumulation of Misfolded Proteins in Neurons
J. Neurosci.,
December 3, 2008;
28(49):
13285 - 13295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Seo, W. Kim, and O. Isacson
Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients
Hum. Mol. Genet.,
October 15, 2008;
17(20):
3144 - 3153.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|